Chimin Health Management Co., Ltd. (SHA:603222)
10.11
-0.20 (-1.94%)
Oct 22, 2025, 2:45 PM CST
Chimin Health Management Revenue
Chimin Health Management had revenue of 185.43M CNY in the quarter ending June 30, 2025, a decrease of -20.11%. This brings the company's revenue in the last twelve months to 676.53M, down -26.13% year-over-year. In the year 2024, Chimin Health Management had annual revenue of 775.73M, down -13.28%.
Revenue (ttm)
676.53M
Revenue Growth
-26.13%
P/S Ratio
7.97
Revenue / Employee
339.28K
Employees
1,994
Market Cap
5.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 775.73M | -118.78M | -13.28% |
| Dec 31, 2023 | 894.51M | 57.27M | 6.84% |
| Dec 31, 2022 | 837.24M | -261.23M | -23.78% |
| Dec 31, 2021 | 1.10B | 220.83M | 25.16% |
| Dec 31, 2020 | 877.64M | 106.36M | 13.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 42.62B |
| WuXi AppTec | 41.90B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |
| Shanghai Fosun Pharmaceutical (Group) | 40.12B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Jiangsu Hengrui Medicine | 30.15B |
| Zhejiang NHU Company | 22.87B |
| Aier Eye Hospital Group | 21.94B |